Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this warning letter issued to Stratus BioSystems, LLC on July 1, 2019 concerns a biologics product, though the specific nature of regulatory violations cannot be determined as the subject line is unavailable. The letter was issued under FDA biologics authority, but without access to the full warning letter text, the particular compliance deficiencies identified cannot be specified. Additional documentation review would be necessary to understand the specific violations and required corrective actions.